These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
431 related items for PubMed ID: 15130902
1. Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state. Tubach F, Ravaud P, Baron G, Falissard B, Logeart I, Bellamy N, Bombardier C, Felson D, Hochberg M, van der Heijde D, Dougados M. Ann Rheum Dis; 2005 Jan; 64(1):34-7. PubMed ID: 15130902 [Abstract] [Full Text] [Related]
2. Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement. Tubach F, Ravaud P, Baron G, Falissard B, Logeart I, Bellamy N, Bombardier C, Felson D, Hochberg M, van der Heijde D, Dougados M. Ann Rheum Dis; 2005 Jan; 64(1):29-33. PubMed ID: 15208174 [Abstract] [Full Text] [Related]
5. Minimal perceptible clinical improvement with the Western Ontario and McMaster Universities osteoarthritis index questionnaire and global assessments in patients with osteoarthritis. Ehrich EW, Davies GM, Watson DJ, Bolognese JA, Seidenberg BC, Bellamy N. J Rheumatol; 2000 Nov; 27(11):2635-41. PubMed ID: 11093446 [Abstract] [Full Text] [Related]
6. Stability of the patient acceptable symptomatic state over time in outcome criteria in ankylosing spondylitis. Tubach F, Pham T, Skomsvoll JF, Mikkelsen K, Bjørneboe O, Ravaud P, Dougados M, Kvien TK. Arthritis Rheum; 2006 Dec 15; 55(6):960-3. PubMed ID: 17139643 [Abstract] [Full Text] [Related]
8. Multicenter, randomized, double-blind, active-controlled, parallel-group trial of the long-term (6-12 months) safety of acetaminophen in adult patients with osteoarthritis. Temple AR, Benson GD, Zinsenheim JR, Schweinle JE. Clin Ther; 2006 Feb 15; 28(2):222-35. PubMed ID: 16678643 [Abstract] [Full Text] [Related]
9. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee. Kivitz A, Ma C, Ahdieh H, Galer BS. Clin Ther; 2006 Mar 15; 28(3):352-64. PubMed ID: 16750450 [Abstract] [Full Text] [Related]
10. A powder made from seeds and shells of a rose-hip subspecies (Rosa canina) reduces symptoms of knee and hip osteoarthritis: a randomized, double-blind, placebo-controlled clinical trial. Winther K, Apel K, Thamsborg G. Scand J Rheumatol; 2005 Mar 15; 34(4):302-8. PubMed ID: 16195164 [Abstract] [Full Text] [Related]
12. Validation of a short form of the Western Ontario and McMaster Universities Osteoarthritis Index function subscale in hip and knee osteoarthritis. Baron G, Tubach F, Ravaud P, Logeart I, Dougados M. Arthritis Rheum; 2007 May 15; 57(4):633-8. PubMed ID: 17471534 [Abstract] [Full Text] [Related]
13. Prognosis of limitations in activities in osteoarthritis of the hip or knee: a 3-year cohort study. van Dijk GM, Veenhof C, Spreeuwenberg P, Coene N, Burger BJ, van Schaardenburg D, van den Ende CH, Lankhorst GJ, Dekker J, CARPA Study Group. Arch Phys Med Rehabil; 2010 Jan 15; 91(1):58-66. PubMed ID: 20103397 [Abstract] [Full Text] [Related]
14. Validation of the Spanish version of the WOMAC questionnaire for patients with hip or knee osteoarthritis. Western Ontario and McMaster Universities Osteoarthritis Index. Escobar A, Quintana JM, Bilbao A, Azkárate J, Güenaga JI. Clin Rheumatol; 2002 Nov 15; 21(6):466-71. PubMed ID: 12447629 [Abstract] [Full Text] [Related]
16. OMERACT/OARSI initiative to define states of severity and indication for joint replacement in hip and knee osteoarthritis. Gossec L, Hawker G, Davis AM, Maillefert JF, Lohmander LS, Altman R, Cibere J, Conaghan PG, Hochberg MC, Jordan JM, Katz JN, March L, Mahomed N, Pavelka K, Roos EM, Suarez-Almazor ME, Zanoli G, Dougados M. J Rheumatol; 2007 Jun 15; 34(6):1432-5. PubMed ID: 17552070 [Abstract] [Full Text] [Related]
17. Management of osteoarthritis (OA) with an unsupervised home based exercise programme and/or patient administered assessment tools. A cluster randomised controlled trial with a 2x2 factorial design. Ravaud P, Giraudeau B, Logeart I, Larguier JS, Rolland D, Treves R, Euller-Ziegler L, Bannwarth B, Dougados M. Ann Rheum Dis; 2004 Jun 15; 63(6):703-8. PubMed ID: 15140778 [Abstract] [Full Text] [Related]
18. A randomized, multicentre, double-blind, parallel-group study to assess the adverse event-related discontinuation rate with celecoxib and diclofenac in elderly patients with osteoarthritis. Dahlberg LE, Holme I, Høye K, Ringertz B. Scand J Rheumatol; 2009 Jun 15; 38(2):133-43. PubMed ID: 19165648 [Abstract] [Full Text] [Related]
19. Responsiveness of the WOMAC osteoarthritis index as compared with the SF-36 in patients with osteoarthritis of the legs undergoing a comprehensive rehabilitation intervention. Angst F, Aeschlimann A, Steiner W, Stucki G. Ann Rheum Dis; 2001 Sep 15; 60(9):834-40. PubMed ID: 11502609 [Abstract] [Full Text] [Related]
20. Treatment of patients with arthrosis of hip or knee with an aqueous extract of devil's claw (Harpagophytum procumbens DC.). Wegener T, Lüpke NP. Phytother Res; 2003 Dec 15; 17(10):1165-72. PubMed ID: 14669250 [Abstract] [Full Text] [Related] Page: [Next] [New Search]